This company has been acquired
Natus Medical Management
Management criteria checks 4/4
Key information
Tom Sullivan
Chief executive officer
US$5.2m
Total compensation
| CEO salary percentage | 0.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600
Jul 22Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Mar 04
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Nov 08We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit
Aug 13Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now
Jun 10Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
May 05Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
Jan 11Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years
Dec 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2022 | n/a | n/a | US$13m |
| Dec 31 2021 | US$5m | US$17k | US$13m |
| Sep 30 2021 | n/a | n/a | US$17m |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$245k | n/a | -US$17m |
| Sep 30 2020 | n/a | n/a | -US$19m |
| Jun 30 2020 | n/a | n/a | -US$1m |
| Mar 31 2020 | n/a | n/a | US$11m |
| Dec 31 2019 | US$86k | n/a | -US$16m |
Compensation vs Market: Tom's total compensation ($USD5.17M) is about average for companies of similar size in the US market ($USD4.04M).
Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.
CEO
Tom Sullivan (58 yo)
less than a year
Tenure
US$5,167,297
Compensation
Mr. Thomas Joseph Sullivan, also known as Tom, has been the Chief Executive Officer and President of Natus Medical Incorporated since December 27, 2021 and serves as its Director. Mr. Sullivan served as Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$5.17m | 0.21% $ 2.4m | |
| Executive VP & CFO | 3.8yrs | US$1.66m | 0.20% $ 2.2m | |
| Executive VP & Chief Commercial Officer | 3.5yrs | US$1.46m | 0.40% $ 4.6m | |
| Vice President of Global Operations | 3.5yrs | no data | no data | |
| Vice President of Global Research & Development | 3.5yrs | no data | no data | |
| Vice President | no data | no data | no data | |
| Chief People Officer & VP | 3.5yrs | no data | no data |
3.5yrs
Average Tenure
57yo
Average Age
Experienced Management: NTUS's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.4yrs | US$5.17m | 0.21% $ 2.4m | |
| Independent Chairperson | 4.1yrs | US$259.51k | 0.11% $ 1.2m | |
| Independent Director | 3.4yrs | US$251.63k | 0.065% $ 738.5k | |
| Independent Director | less than a year | US$182.90k | 0.030% $ 333.4k | |
| Independent Director | 2.3yrs | US$255.51k | 0.055% $ 624.1k | |
| Independent Director | 4.1yrs | US$238.51k | 0.077% $ 866.5k | |
| Independent Director | less than a year | US$180.27k | 0.030% $ 333.4k |
3.4yrs
Average Tenure
58yo
Average Age
Experienced Board: NTUS's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/07/22 19:55 |
| End of Day Share Price | 2022/07/20 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Natus Medical Incorporated is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Raymond Myers | Benchmark Company |
| Lawrence Solow | CJS Securities, Inc. |